Herpes Simplex Virus -1/2 (HSV-1/2) PCR Detection, in Visit Clinic

The PCR test for HSV‑1 and HSV‑2 is a molecular assay that detects herpes simplex viral DNA from lesion swabs, cerebrospinal fluid, or other clinical samples. It reliably distinguishes HSV‑1 from HSV‑2, is more sensitive and faster than culture, and diagnoses active infection (including encephalitis). Results are usually available within 24–72 hours. It differs from antibody tests, which detect past exposure.

Herpes simplex is diagnosed by direct testing of lesions and by blood antibody tests. Lesion swabs are tested by PCR (most sensitive and distinguishes HSV‑1 vs HSV‑2) or by viral culture from fresh vesicles. Type‑specific serology (HSV‑1/HSV‑2 IgG) detects past infection when no lesion is available; IgM is unreliable. For suspected encephalitis, CSF PCR is used.

Costs vary by country, clinic and insurance: many public sexual‑health services offer free testing, while private lab or clinic herpes PCR typically costs about INR 800–4,000 in India, £30–150 in the UK, and roughly $50–250 in the US (higher without insurance or for specialist labs). Ask your local clinic or lab for exact pricing and insurance coverage.

A PCR test for HSV involves a quick sample (swab, blood or CSF) and lab amplification. Most results are available within 24–72 hours; lesion swab PCR often returns in 24–48 hours. Some clinics or rapid platforms can deliver results in a few hours, while samples sent to reference labs may take several days. Turnaround depends on sample type and laboratory workflow.

Yes — HSV PCR is highly accurate but not infallible. False negatives can occur with poor or late sampling, low viral load, or PCR inhibitors; false positives are rare but can result from contamination. Results should be interpreted with clinical context; repeat testing, improved lesion sampling, or type‑specific serology can clarify uncertain cases.

A PCR test detects the genetic material (DNA or RNA) of a specific pathogen. For RNA viruses (e.g., SARS‑CoV‑2) the sample undergoes reverse transcription then amplification (RT‑PCR) to identify virus‑specific RNA sequences. PCR confirms current infection by finding pathogen nucleic acids with high sensitivity, even at low levels, but it doesn't directly measure infectiousness or immune response.